blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1019035

EP1019035 - IL-8 RECEPTOR ANTAGONISTS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  07.02.2003
Database last updated on 24.08.2024
Most recent event   Tooltip07.02.2003Application deemed to be withdrawnpublished on 26.03.2003  [2003/13]
Applicant(s)For all designated states
SMITHKLINE BEECHAM CORPORATION
One Franklin Plaza
Philadelphia, PA 19102 / US
[2000/29]
Inventor(s)01 / XIANG, Jia-Ning
306 Danor Court
Wayne, PA 19087 / US
[2000/29]
Representative(s)Blakey, Alison Jane
GlaxoSmithKline
Corporate Intellectual Property
Two New Horizons Court
Brentford, Middlesex
TW8 9EP / GB
[N/P]
Former [2000/29]Blakey, Alison Jane
Smithkline Beecham, Corporate Intellectual Property, Two New Horizons Court
Brentford, Middlesex, TW8 9EP / GB
Application number, filing date97939478.021.08.1997
[2000/29]
WO1997US14729
Priority number, dateUS19960024501P21.08.1996         Original published format: US 24501 P
[2000/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9807418
Date:26.02.1998
Language:EN
[1998/08]
Type: A1 Application with search report 
No.:EP1019035
Date:19.07.2000
Language:EN
The application published by WIPO in one of the EPO official languages on 26.02.1998 takes the place of the publication of the European patent application.
[2000/29]
Search report(s)International search report - published on:US26.02.1998
(Supplementary) European search report - dispatched on:EP04.09.2001
ClassificationIPC:C07C311/51, A61K31/17
[2001/42]
CPC:
A61K31/18 (EP,US); A61K31/17 (EP,US); A61P37/00 (EP);
C07C311/51 (EP,US); Y02A50/30 (EP,US)
Former IPC [2000/29]A61K31/17, A61K31/44, A61K31/54, A61K31/495, A61K31/505, A61K31/535, C07D213/56, C07D213/84, C07D213/86, C07D213/88, C07D251/32
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2000/29]
TitleGerman:IL-8-REZEPTORANTAGONISTEN[2000/29]
English:IL-8 RECEPTOR ANTAGONISTS[2000/29]
French:ANTAGONISTES DU RECEPTEUR D'IL-8[2000/29]
Entry into regional phase04.02.1999National basic fee paid 
04.02.1999Search fee paid 
04.02.1999Designation fee(s) paid 
04.02.1999Examination fee paid 
Examination procedure06.03.1998Request for preliminary examination filed
International Preliminary Examining Authority: US
04.02.1999Examination requested  [2000/29]
10.05.2002Despatch of a communication from the examining division (Time limit: M04)
21.09.2002Application deemed to be withdrawn, date of legal effect  [2003/13]
25.10.2002Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2003/13]
Fees paidRenewal fee
04.08.1999Renewal fee patent year 03
07.08.2000Renewal fee patent year 04
06.08.2001Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.08.200206   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[E]WO9745400  (NEUROSEARCH AS [DK], et al) [E] 1* page 17, line 15 - line 16 *
International search[X]US5262415  (TAKEMOTO TADAHIRO [JP], et al);
 [X]  - MANLEY P. W., QUAST U., "STRUCTURE-ACTIVITY STUDIES OF POTASSIUM CHANNEL OPENING IN PINACICIL-TYPE CYANOGUANIDINES, NITROETHENEDIAMINE, THIOUREAS, AND UREAS.", Journal of Medicinal Chemistry, American Chemical Society, US, US, (19920612), vol. 35., no. 12., doi:10.1021/jm00090a025, ISSN 0022-2623, pages 2327 - 2340., XP000566901

DOI:   http://dx.doi.org/10.1021/jm00090a025
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.